DNA sequences from BK virus have been detected by measurements of reassociation kinetics in DNA preparations isolated from five of 12 human tumor tissues and three of four human tumor cell lines; no DNA sequences from BK virus could be found using the same assay in DNA samples obtained from nontumor tissues removed from various patients. MATERIALS AND METHODS Cells and Virus. BKV was grown in human embryonic kidney cell cultures before infection in Dulbecco's modified Eagle's medium with 10% fetal calf serum, and after infection with 2% fetal calf serum (4, 9). To limit the accumulation of defective genomes, we infected the cultures with plaque purified virus at a multiplicity of infection of 10-2 plaque-forming unit/cell. In the description of the human tumor cell lines and of the frozen tumors and noncancerous human tissues (controls), we will use, as a means of identification, the figure and the panel number corresponding to the reassociation kinetics of each given test DNA. The human tumor cell lines were originally isolated by Dr. Aaronson and obtained from him. The following cell lines were used in this study: A-549 (Fig. 3, no. 15), carcinoma of the lung, passage 95; A-375 (Fig. 3, no. 16), melanoma, passage 114; A-204 (Fig. 3, no. 17) , rhabdomyosarcoma, passage 88; and A-10iD (Fig. 3, 
Gardner et al. (1) first isolated BK virus (BKV) from the urine of a renal allograft recipient. Gardner also reported (2) that, using inhibition of hemoagglutination and complement fixation techniques, antibodies to BKV were widespread (83%) in the human population of England. A similar frequency was found amongst the population of the United States (3) . Some time ago (4) we showed that BKV is able to induce malignant transformation of BHK 21 cl. 13 cells. Induction of tumors in hamster by BKV has been reported (5-7). BKV and simian virus 40 differ widely in their major structural proteins, as judged by their limited immunologic crossreactivity (8) and quite different tryptic peptides (9) . On the other hand, the two viruses induce indistinguishable T-antigen, as judged by immunofluorescence, complement fixation (6, 10, 11) , and immunoprecipitability (12) . Measurements of DNA-DNA reassociation kinetics using hydroxyapatite show that only 20% of the viral DNA sequences are common (13) and the common sequences are in the "late" region of the genomes. Similar measurements of the DNA-DNA reassociation kinetics using SI nuclease (14) show that there is only 5% homology between the two genomes (Fiori and di Mayorca, unpublished data). Using serology and tryptic chromatography to compare structural proteins, we found that four BKV independently isolated from different geographical areas in the world were very similar to the prototype BKV (8) . Moreover, the nucleotide sequences of the DNA of these four isolates and the prototype BKV were entirely homologous, as judged by DNA-DNA reassociation kinetics (SI) (Fiori and di Mayorca, unpublished results).
Quite clearly, a large proportion of the human population throughout the world has been infected or exposed to BKV. But, aside from human cell cultures, BKV multiplication has been detected only in immunosuppressed patients, e.g., individuals who have been deliberately immunosuppressed to accept renal allografts or patients who have genetic defects that render them immunodeficient (15, 16 (4, 9) . To limit the accumulation of defective genomes, we infected the cultures with plaque purified virus at a multiplicity of infection of 10-2 plaque-forming unit/cell. In the description of the human tumor cell lines and of the frozen tumors and noncancerous human tissues (controls), we will use, as a means of identification, the figure and the panel number corresponding to the reassociation kinetics of each given test DNA. The human tumor cell lines were originally isolated by Dr. Aaronson and obtained from him. The following cell lines were used in this study: A-549 (Fig. 3, no. 15), carcinoma of the lung, passage 95; A-375 (Fig. 3, no. 16 ), melanoma, passage 114; A-204 (Fig. 3, no. 17 ), rhabdomyosarcoma, passage 88; and A-10iD (Fig. 3, (18) . Cell nuclear DNA was isolated essentially as described by Folk (19) . The purified DNAs were sonicated ten times for 30-sec bursts with a blunt-probe Branson sonifier. The fragments, which were judged to be 300-400 nucleotides long from their sedimentation at 5.7S in an alkaline sucrose gradient, were used for the reassociation experiments. The tumors, which were stored frozen up to 30 min before the extraction, were diced into small Si nuclease, and after denaturation only 3-6% of the DNA remained acid-precipitable after digestion by SI nuclease.
Hybridization Tests. The reannealing reactions, done at 68°i n 10 mM Tris-HCl (pH 7.8), 1 mM EDTA, 1.5 M NaCI, contained 1.5-4 X 10-3, g/ml of the 3H-labeled BKV DNA (depending on the specific activity of the probe), the sonicated test DNA (5.7S), and/or sonicated salmon sperm DNA (5.7S) at a final concentration of 5.0 mg/ml (see legend to Fig. 1 ). The mixtures, ranging in volume from 0.5 to 1 ml, were boiled for 5 min, quenched on ice-water, adjusted to 1.5 M in NaCl, and reannealed at 680.
Assays for Duplex DNA. Reassociation was monitored by measuring the formation of double-stranded, labeled BKV DNA that was resistant to S nuclease, as described (14, 21 
RESULTS
The reassociation kinetic plots obtained with BKV DNA in the presence of salmon sperm DNA (Fig. 2, no. 1 ) and DNA from 12 different nontumor tissues ( Fig. 1 and Fig. 2, no. 2) show no significant acceleration of the rate of reannealing. Fig. 2 (no. 1) shows that the addition of 0.5 and 1 genome equivalent (per cell genome) of BKV DNA produces the expected increase in the reannealing rate. With DNA obtained from tumors, there was a significant increase in the reannealing rate with five of the 12 samples (Figs. 2 and 3) . Also, DNA from three of four cell lines derived from tumors significantly increased the reannealing rate of BKV DNA (Fig. 3) . In one Wilms tumor (Fig. 2, It is of interest and some importance that there was no detectable BKV DNA in the kidney tissue from a patient undergoing heavy immunosuppression for kidney transplantation, since it is from such patients that BKV is frequently isolated.
There is no apparent correlation between the finding of BKV DNA in the tumors and prior therapeutic treatment. Table 1 shows that of the five tumors containing BKV DNA, two were from patients that had not been treated, and two were from patients treated with chemotherapy and/or radiation. Of the seven negative tumors, four came from patients treated with chemotherapy and/or radiation, whereas there was no information for two and one was not treated. The tumor cell lines A-549, A-375, and A-101D, which contained significant amounts of BKV DNA in their DNAs, have been tested by plaque assay of lysates and by infectious center assay for the presence of infectious BKV in conditions where we could have detected 1 plaque-forming unit for 106 cells (lysate) or one virus producing cell in 106. The results of the two assays were negative (Fiori and di Mayorca, unpublished results).
The same cell lines were tested for the expression of T-antigen by complement fixation and immunofluorescence assays, provide the best source of cell DNA for establishing the physical state of the viral genomes (e.g., virion, plasmid, or integrated). Until then, it would be careless to conclude more than that detectable levels of BKV DNA are present in about one-third of the human tumors we have examined and are absent from 12 samples of normal human tissues; in addition, three of four cultured human cell lines contained significant levels of BKV DNA. It would also be premature to accept any causal or associative relationships of BKV and the occurrence of tumors, although such correlations could emerge from future studies.
